Evogene Ltd (EVGN)

[Fress]

Great news we just got 28 million from Canter Fitzgerald.


broke a 52 week high and multi year today!!



EVGN gets the upper hand here can sell when they want too this reminds me of another company that I invested in recently & then the share price flew 175%+. a few weeks later.



this company now has plenty of cash & no debt.


I just bought another 5k shares after hours under $6.00


will buy 10-20k more shares tomorrow in increments between $6.00-$7.00 before it blast off into double digits and beyond.




Cathie Wood ARKG ETF & Cantor Fitzgerald owns EVGN and expects exponential growth and scaling on multiple fronts from this cutting edge gene editing AI technology protocol.


EVGN Subsidiaries:
Evogene group supports independent entities focusing on a defined commercial field with an exclusive license to use our unique solution for product development.

1.Biomica
https://www.biomicamed.com/
2.Canonic
https://canonicbio.com/
3.AgPlenus
https://www.agplenus.com/
4.Lavie Bio
https://www.lavie-bio.com/
5.Castera
https://www.evogene.com/wp-content/uploads/2019/05/Casterra-company-presentation-ICOA-_pdf-version.pdf


Evogene to Participate in CRISPR-IL Consortium to Provide End-to-End Artificial Intelligence System for Genome-Editing.
https://www.prnewswire.com/il/news-releases/evogene-to-participate-in-crispr-il-consortium-to-provide-end-to-end-artificial-intelligence-system-for-genome-editing-301069960.html



Genome Stocks-Gene Editing.
$PACB 6.2 billion market cap
$BEAM 5.4 billion market cap
$CRSP 13 billion market cap
$EDIT 4.8 billion market cap
$SGMO 2.3 billion market cap
$NTLA 4.8 billion market cap
$BLUE 3.3 billion market cap
$BNGO 1.2 billion market cap
$EVGN 200 million market cap 35 million shares 45% owned by institutions & insiders.



$EVGN